Next Article in Journal
Approved and Off-Label Uses of Obesity Medications, and Potential New Pharmacologic Treatment Options
Next Article in Special Issue
Cell Permeable Peptides: A Promising Tool to Deliver Neuroprotective Agents in the Brain
Previous Article in Journal
A Novel Category of Anti-Hypertensive Drugs for Treating Salt-Sensitive Hypertension on the Basis of a New Development Concept
Previous Article in Special Issue
Fusion of a Short HA2-Derived Peptide Sequence to Cell-Penetrating Peptides Improves Cytosolic Uptake, but Enhances Cytotoxic Activity
Pharmaceuticals 2010, 3(1), 110-124; doi:10.3390/ph3010110

Notes on Article Versions

Action Date Notes Link
article html file updated 18 January 2013 01:22 CET Original file -
article html file updated 21 January 2013 19:16 CET Update -
article html file updated 25 January 2013 20:41 CET Update -
article html file updated 28 January 2013 18:05 CET Update -
article html file updated 5 February 2013 20:28 CET Update -
article html file updated 6 February 2013 16:19 CET Update -
article xml file uploaded 28 April 2014 11:00 CEST Original file http://www.mdpi.com/1424-8247/3/1/110/xml
article html file updated 28 April 2014 11:00 CEST Update -
article html file updated 16 June 2015 07:53 CEST Update http://www.mdpi.com/1424-8247/3/1/110/html
Pharmaceuticals EISSN 1424-8247 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert